{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:29:23Z","timestamp":1792690163554,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Premenstrual dysphoric disorder (PMDD) is defined by both physical and psychiatric symptoms that impact a woman significantly during the luteal phase of her menstrual cycle. Diagnostic criteria for PMDD were firmly established in the Diagnostic and Statistical Manual of Mental Disorders V in 2013, but many patients fall short of the diagnosis while still appreciably affected by severe premenstrual symptoms. More recent and robust investigations have evaluated the efficacy of treatment ranging from serotonergic therapy to hormonal treatment as well as lifestyle and herbal remedies. This article reviews the evidence for diagnosis and treatment of PMDD.<\/jats:p>","DOI":"10.1097\/grf.0000000000000339","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T22:58:32Z","timestamp":1515020312000},"page":"52-61","source":"Crossref","is-referenced-by-count":76,"title":["Premenstrual Syndrome: Evidence-based Evaluation and Treatment"],"prefix":"10.1097","volume":"61","author":[{"given":"SARAH M.","family":"APPLETON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 3","key":"R2-20240213","first-page":"1","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD)","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R3-20240213","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.whi.2009.09.005","article-title":"Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity","volume":"20","author":"Heinemann","year":"2010","journal-title":"Womens Health Issues"},{"key":"R4-20240213","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/07399332.2011.610530","article-title":"Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities","volume":"33","author":"Heinemann","year":"2012","journal-title":"Health Care Women Int"},{"key":"R5-20240213","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily record of severity of problems (DRSP): reliability and validity","volume":"9","author":"Endicott","year":"2006","journal-title":"Arch Womens Ment Health"},{"key":"R6-20240213","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00737-003-0018-4","article-title":"The premenstrual symptoms screening tool (PSST) for clinicians","volume":"6","author":"Steiner","year":"2003","journal-title":"Arch Womens Ment Health"},{"key":"R7-20240213","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/jwh.2008.1098","article-title":"Exercise and premenstrual symptomatology: a comprehensive review","volume":"18","author":"Daley","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"R8-20240213","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","article-title":"Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms","volume":"179","author":"Thys-Jacobs","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20240213","first-page":"e407","article-title":"Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review","volume":"16","author":"Whelan","year":"2009","journal-title":"Can J Clin Pharmacol"},{"key":"R10-20240213","first-page":"400","article-title":"Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome","volume":"32","author":"London","year":"1987","journal-title":"J Reprod Med"},{"key":"R11-20240213","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.322.7279.134","article-title":"Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study","volume":"322","author":"Schellenberg","year":"2001","journal-title":"BMJ"},{"key":"R12-20240213","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hup.470","article-title":"Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder","volume":"18","author":"Atmaca","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"R13-20240213","first-page":"CD001396","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","volume":"6","author":"Marjoribanks","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"pt 1","key":"R14-20240213","first-page":"737","article-title":"Venlafaxine in the treatment of premenstrual dysphoric disorder","volume":"98","author":"Freeman","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R15-20240213","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00737-013-0346-y","article-title":"ISPMD consensus on the management of premenstrual disorders","volume":"16","author":"Nevatte","year":"2013","journal-title":"Arch Womens Ment Health"},{"key":"R16-20240213","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/01674820209074672","article-title":"A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder","volume":"23","author":"Hunter","year":"2002","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"R17-20240213","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0002-9378(03)00927-X","article-title":"Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration","volume":"189","author":"Joffe","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20240213","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"R19-20240213","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"2","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-20240213","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","article-title":"Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives","volume":"89","author":"Dinger","year":"2014","journal-title":"Contraception"},{"key":"R21-20240213","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0015-0282(16)54718-9","article-title":"Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes","volume":"56","author":"Halbreich","year":"1991","journal-title":"Fertil Steril"},{"key":"R22-20240213","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R23-20240213","first-page":"779","article-title":"Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial","volume":"84","author":"Brown","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R24-20240213","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/humrep\/deh354","article-title":"Studd Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome","volume":"19","author":"Cronje","year":"2004","journal-title":"Hum Reprod"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201803000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T06:00:41Z","timestamp":1707804041000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201803000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000339","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}